Evidence against resveratrol as a viable therapy for the rescue of defective ΔF508 CFTR

Taken together, our results do not support the use of resveratrol supplements as a therapy for patients with cystic fibrosis. It is possible that further modifications of the resveratrol backbone would yield a more efficacious compound.